JPM
57
-5
L
47
-5
FSLR
63
6
MHK
43
4
HIG
52
2
C
50
-4
WHR
64
3
DVA
59
4
LMT
27
-2
AME
62
3
CHD
42
-3
OKE
65
4
OMC
59
4
GOOG
55
-4
EQR
44
7
HES
62
4
CMG
57
-6
AEP
43
3
WAT
66
2
CMCSA
59
6
JPM
57
-5
L
47
-5
FSLR
63
6
MHK
43
4
HIG
52
2
C
50
-4
WHR
64
3
DVA
59
4
LMT
27
-2
AME
62
3
CHD
42
-3
OKE
65
4
OMC
59
4
GOOG
55
-4
EQR
44
7
HES
62
4
CMG
57
-6
AEP
43
3
WAT
66
2
CMCSA
59
6
Financhill
Back

FibroGen Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
41

FGEN
FibroGen

Last Price:
0.31
Seasonality Move:
45.73%
Buy
54

BMRN
Biomarin Pharmaceutical

Last Price:
65.90
Seasonality Move:
13.3%
Sell
41
FibroGen (FGEN) is a Sell

Is FibroGen a Buy, Sell or Hold?

  • The current FibroGen [FGEN] share price is $0.32. The Score for FGEN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • FGEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $66.00. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

FGEN Stock Price Chart

What is FibroGen's stock price today?

  • The FibroGen share price today is $0.32
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FGEN is experiencing selling pressure, which indicates risk of future bearish movement.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $66.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight selling pressure.

FGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 42.59 Sell
Chaikin Money Flow: -131340 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.32 - 0.38) Sell
Bollinger Bands (100): (0.28 - 0.92) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.93 Sell
Relative Strength Index (14 RSI): 29.43 Sell
Chaikin Money Flow: -205272 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (67.87 - 70.73) Sell
Bollinger Bands (100): (71.95 - 88.51) Sell

FGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.31 Buy
20-day SMA: 0.33 Sell
50-day SMA: 0.37 Sell
200-day SMA: 1.1 Sell
8-day EMA: 0.32 Buy
20-day EMA: 0.34 Sell
50-day EMA: 0.41 Sell
200-day EMA: 1.35 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 68.17 Sell
20-day SMA: 69.24 Sell
50-day SMA: 75.04 Sell
200-day SMA: 82.85 Sell
8-day EMA: 67.65 Sell
20-day EMA: 69.3 Sell
50-day EMA: 73.55 Sell
200-day EMA: 81.57 Sell

FibroGen Earnings Growth & FGEN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and an increase next year of $0.65 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.

FibroGen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):